Patent · US Active

Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use

US11241430B2 · kind B2 · utility

0Cited by

32References

11Claims

0Family size

Assignee

Signal Pharmaceuticals, LLC · US

Inventors

Marie Georges Beauchamps · Dover, US
Robert Hilgraf · Cambridge, US
Mohit Atul Kothare · Bound Brook Junction, US
Hon-Wah Man · Princeton, US
Mark A. Nagy · San Diego, US

Key dates

Filing date	Nov 11, 2019
Grant date	Feb 8, 2022
Priority date	—
Expiry date	Apr 10, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D239/48
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are formulations, processes, solid forms and methods of use relating to 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.